Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Bretton Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"The Bretton Fund returned 2.70% in Q2 2025, lagging the S&P 500's 10.94% due to a steep sell-off in UnitedHealth Group, but managers remain confident in UNH's long-term value and repricing capabilities."
In their Q2 2025 shareholder letter, portfolio managers Stephen Dodson and Raphael de Balmann discuss the Bretton Fund's quarterly return of 2.70%, which lagged the S&P 500 Index's 10.94% return. The underperformance was primarily driven by a dramatic decline in UnitedHealth Group (UNH), which lost over half of its market value during the quarter, dragging the fund's overall performance down by 2.0%. Other detractors included Progressive (down 0.5%) and Eagle Materials (down 0.4%), which reported disappointing earnings. Conversely, positive contributors included Microsoft (up 1.4%), Alphabet (up 1.1%), and American Express (up 1.1%). The managers dedicate a significant portion of the letter to analyzing UnitedHealth Group's medical utilization challenges, noting that higher-than-expected consumption in Medicare Advantage and OptumHealth led to downward guidance revisions and the replacement of CEO Andrew Witty with Stephen Hemsley. Despite these short-term headwinds and an ongoing Department of Justice investigation, Bretton Fund remains constructively positioned on UNH, viewing the stock as highly attractive at its compressed valuation of approximately 10x earnings and believing the business's core fundamentals remain intact.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Bretton Fund returned 2.70% in Q2 2025, lagging the S&P 500's 10.94% due to a steep sell-off in UnitedHealth Group, but managers remain confident in UNH's long-term value and r...
Growth Outlook
Market outlook remains high conviction: The Bretton Fund returned 2.70% in Q2 2025, lagging the S&P 500's 10.94% due to a steep sell-off in UnitedHealth Group, but managers remain confident in UNH's long-term value and r...
Risk Appetite
Risk appetite posture is high conviction: The Bretton Fund returned 2.70% in Q2 2025, lagging the S&P 500's 10.94% due to a steep sell-off in UnitedHealth Group, but managers remain confident in UNH's long-term value and r...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Bretton Fund returned 2.70% in Q2 2025, lagging the S&P 500's 10.94% due to a steep sell-off in UnitedHealth Group, but managers remain confident in UNH's long-term value and r...
Forward Guidance
Forward guidance signal: The Bretton Fund returned 2.70% in Q2 2025, lagging the S&P 500's 10.94% due to a steep sell-off in UnitedHealth Group, but managers remain confident in UNH's long-term value and r...
Language Signal
Tone analysis indicates high conviction language: The Bretton Fund returned 2.70% in Q2 2025, lagging the S&P 500's 10.94% due to a steep sell-off in UnitedHealth Group, but managers remain confident in UNH's long-term value and r...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Bretton Fund returned 2.70% in Q2 2025, lagging the S&P 500's 10.94% due to a steep sell-off in UnitedHealth Group, but managers remain confident in UNH's long-term value and r...
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. The Bretton Fund returned 2.70% in Q2 2025, lagging the S&P 500's 10.94% due to a steep sell-off in UnitedHealth Group, but managers remain confident in UNH's long-term value and r...
Time Horizon
Investment time horizon reflects a high conviction orientation. The Bretton Fund returned 2.70% in Q2 2025, lagging the S&P 500's 10.94% due to a steep sell-off in UnitedHealth Group, but managers remain confident in UNH's long-term value and r...
